A clinical trial to investigate ADX71441 for the treatment of cocaine use disorder
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2019
At a glance
- Drugs ADX 71441 (Primary)
- Indications Cocaine abuse
- Focus Adverse reactions
- 07 Jan 2019 According to an Addex Therapeutics media release, the company plans to enter phase 1 trial during Q2 2019.
- 05 Oct 2017 New trial record
- 03 Oct 2017 According to an Addex Therapeutics media release, this trial will be conducted in coordination with the Friends Research Institute (FRI) and principal investigator, Dr. Frank J. Vocci. The studies are expected to begin in the first half of 2018.